Abstract:OBJECTIVE:To study the reduced folate carrier gene (RFC1) A80G polymorphism and other factors influence on children with neural tube defects (NTDs) and provide the epidemiological evidence for finding genetic marker of NTDs. METHODS:RFC1(A80G) genotypes were detected using polymerase chain reaction-restriction fragment length polymorphism (RFLP-PCR) for blood DNA of 104 trios with NTDs-affected by child, and the 100 control families without child-affected by any birth defects. We performed the analysis of multifactors logistic regression for RFC1 genotypes and other factors in order to investigate the RFC1 genotype of the nuclear families and maternal periconceptional folic acid supplementation influence on NTDs independently. Transmission/disequilibrium test (TDT) for the RFC1 genotype of NTDs and control pedigree were carried out. RESULTS:The RFC1 G allele frequency of children with NTDs (64.42%) was higher than that of the control children (52.53%), and there was the significant difference between them (chi(2)=5.9198, P<0.05). We observed that the infants of the GG genotype were associated with a 2.56-fold increased risk of NTDs when compared with the AA genotype (95% CI=1.04-6.36), The risk of mothers who did not take folic acid for having an NTDs-affected infants was 7.69 (95% CI=2.86-21.75). There were significant differences between cases and controls in the other risk factors, such as paternal age (> or =30), maternal fever during the early pregnancy, the history of maternal spontaneous abortion. In the logistic regression analysis, of multifactors the three factors, for example, the offspring of the RFC1 GG genotype (OR=2.91, 95% CI=1.35-6.30), maternal periconceptional folic acid supplementation (OR=4.32, 95% CI=1.62-11.55), maternal fever during the early pregnancy, had the statistic significance for the risk of NTDs. There was the evidence of an association between G allele and the risk of the maternal having a child with NTDs (OR=1.56, 95% CI=1.07-2.28) in TDT analysis. CONCLUSION:Our findings indicate that the RFC1 genotype (GG) is a possible susceptible gene marker for an increased NTDs risk in this Chinese population, and there is a potential influence on the risk of NTDs in maternal periconceptional folic acid supplementation, and maternal fever during the early pregnancy.

[Advances in the Study of the Etiologic Relationship Between Reduced Folate Carrier Gene (RFC1) and Neural Tube and Craniofacial Defects].

Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population.

Association of Reduced Folate Carrier Gene Polymorphism and Maternal Folic Acid Use with Neural Tube Defects

Effects of Folic Acid Supplementation During Different Pregnancy Periods and Relationship with the Other Primary Prevention Measures to Neural Tube Defects

[Epidemiological Study on Reduced Folate Carrier Gene(rfc1 A80G) Polymorphism and Other Risk Factors of Neural Tube Defects].

Interaction Between Maternal Periconceptional Supplementation of Folic Acid and Reduced Folate Carrier Gene Polymorphism of Neural Tube Defects

Study on the Association Between Reduced Folate Carrier Gene Polymorphism and Congenital Heart Defects and Cleft Lip with or Without Cleft Palate

Reduced Folate Carrier A80G Polymorphism and Susceptibility to Neural Tube Defects: A Meta-Analysis

[A Parental Case Control Study on the Association Between Reduced Folate Carrier Gene Polymorphism and Neural Tube Defects].

Nutrition, One-Carbon Metabolism and Neural Tube Defects: A Review

Genetic Variation of Infant Reduced Folate Carrier (A80G) and Risk of Orofacial Defects and Congenital Heart Defects in China.

Association between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: a meta-analysis.

Genetic Variants in the Folate Pathway and the Risk of Neural Tube Defects: A Meta-Analysis of the Published Literature

High Ratios of C20:4n-6/C20:5n-3 and Thromboxane B2 /6-Keto-prostaglandin F1α in Placenta Are Potential Risk Contributors for Neural Tube Defects: A Case-Control Study in Shanxi Province, China.

Association of Neural Tube Defects with Maternal Alterations and Genetic Polymorphisms in One-Carbon Metabolic Pathway

High Ratios Of C20:4n-6/C20:5n-3 And Thromboxane B-2/6-Keto-Prostaglandin F-1 Alpha In Placenta Are Potential Risk Contributors For Neural Tube Defects: A Case-Control Study In Shanxi Province, China

Association of Main Folate Metabolic Pathway Gene Polymorphisms with Neural Tube Defects in Han Population of Northern China

Study on Reduced Folate Carrier Gene(rfc1) Polymorphism in the Southern and Northern Chinese Population

Family-Based Association Test for Reduced Folate Carrier Gene Polymorphism of Parent and Offspring with Neural Tube Defects

Population Red Blood Cell Folate Concentrations for Prevention of Neural Tube Defects: Bayesian Model.

Network correlation analysis revealed potential new mechanisms for neural tube defects beyond folic acid.